Quick Reference Guide:
News Releases
January 27, 2012 - Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrx for U.S. Co-Promotion of Granisol® (Granisetron) Oral Solution and Aquoral™ Spray and Purchase of Non-U.S. Rights to Granisol®
January 19, 2012 - PediatRx Reports Revenues and Third Quarter Results
October 20, 2011 - PediatRx Reports Revenues and Second Quarter Results
September 15, 2011 - PediatRx Appoints Paul J. Richardson to Board of Directors
September 14, 2011 - PediatRx Enters U.S. Co-Promotion Agreement for AQUORAL
July 26, 2011 - PediatRx Reports Revenues and First Quarter Results
July 06, 2011 - PediatRx Obtains State Licenses and Begins Direct Sales to Wholesalers and Distributors Through ICS
June 01, 2011 - 80% of Oncologists Prefer Medications With No Patient Out-of-Pocket Costs
May 26, 2011 - PediatRx Reports Revenues and Fiscal Year-End Results
May 06, 2011 - PediatRx Releases Data On Co-pay Assistance Programs In Oncology
April 20, 2011 - PediatRx Comments on Fear of Nausea in Cancer Therapy
February 01, 2011 - PediatRx Launches GRANISOL Co-Pay Program To Support Use Of The Only FDA-Approved, Ready-To-Use Oral Liquid Solution Of GRANISETRON
January 24, 2011 - PediatRx Reports its First-Ever Revenues Following the Launch of GRANISOL
January 06, 2011 - PediatRx Inc., Unique Hospital Specialty Pharma, Begins Trading
November 02, 2010 - PediatRx Launches GRANISOL, the Only FDA-Approved, Ready-To-Use Oral Liquid Solution of GRANISETRON
Copyright © 2001-2012 Primoris Group Inc.
Home | Services | News Releases | Media | Testimonials | Links | Contact Us